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Arsenite Suppresses Notch1 Signaling in Human
Keratinocytes
Tatiana V. Reznikova1, Marjorie A. Phillips1 and Robert H. Rice1
Arsenic is a well-known human skin carcinogen whose mechanism of action remains to be elucidated. In this
work using cultured human epidermal cells, arsenite suppressed accumulation of the transcriptionally active
intracellular domain of Notch1. The cells responded to an active peptide from the Notch1 ligand, Jagged1, with
increased levels of differentiation marker mRNAs and decreased colony-forming ability. Arsenite suppressed
Jagged1 effects and expression of Jagged1 mRNA as well. Moreover, exposure of the cells to a g-secretase
inhibitor prevented Notch1 processing, decreased cell size and differentiation marker expression, and
increased proliferative potential, all effects that occur with arsenite treatment. Thus, arsenite action in
suppressing keratinocyte differentiation while maintaining germinative capability could be due to inhibition of
Notch1 signaling subsequent to ligand binding. This work also revealed that such arsenite action depends upon
epidermal growth factor receptor kinase activity. These findings may help to explain how arsenite, by decreasing
generation of the tumor suppressor Notch1, contributes to skin carcinogenesis.
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INTRODUCTION
The Notch signaling pathway regulates a broad spectrum of
developmental processes as a result of contact between a
membrane receptor of the Notch family with a transmem-
brane ligand of the Delta or Jagged (Serrate) families on an
adjacent cell (Artavanis-Tsakonas et al., 1999). The Notch1
membrane receptor is synthesized as a 300 kDa precursor
that undergoes three distinct cleavages (Fortini, 2002). First,
cleavage in the trans-Golgi network by a furin-like convertase
produces a noncovalently associated heterodimer at the cell
surface. Upon binding a ligand from an adjoining cell, the
receptor is then cleaved extracellularly close to the trans-
membrane domain by a disintegrin/metalloprotease family
member, tumor necrosis factor-a-converting enzyme. The
membrane-anchored carboxy-terminal product of this clea-
vage is subsequently processed by the g-secretase complex,
leading to release of the Notch1 intracellular domain (NICD),
which translocates into the nucleus and binds the transcrip-
tion factor RBP-Jk, resulting in transcriptional repression or
activation of Notch target genes. The best-characterized
targets of Notch-regulated transcriptional activation are
members of the HES and HERP families of basic helix-loop-
helix transcriptional repressors (Iso et al., 2003).
The Notch signaling pathway is important in determining
keratinocyte fate. Notch1 is expressed throughout the living
layers of human interfollicular epidermis with highest levels
observed in the spinous layer (Lowell et al., 2000; Nickoloff
et al., 2002). Overexpression of the ligand Delta1 in
adjoining epidermal cells in culture promotes differentiation
of putative stem cells (Lowell et al., 2000), and treatment of
cultures with an active peptide from the ligand Jagged1
increases expression of differentiation markers (Nickoloff
et al., 2002). Similar findings in mouse keratinocyte cultures
(Rangarajan et al., 2001) led to the demonstration of Notch1
as a tumor suppressor in mouse skin, where its ablation led to
increased incidence of spontaneous tumors and to promotion
of dimethylbenzanthracene carcinogenicity (Nicolas et al.,
2003). Notch1 expression is frequently depressed in human
squamous cell carcinomas and cell lines derived from them,
whereas suppression of Notch1 signaling in culture increases
clonal growth capability of the normal epidermal cells and, in
cells transplanted to mouse skin, promotes tumors induced by
oncogenic ras (Lefort et al., 2007). Interference with Notch1
signaling by expressing a dominant negative mastermind-like
protein, a transcriptional coactivator associated with the
NICD, has now produced a mouse model for human
squamous cell carcinoma (Proweller et al., 2006).
Arsenic, a well-known human carcinogen, produces
cancer of the skin and other organs upon chronic exposure
to high levels in drinking water. Elucidating a mechanistic
basis for such action in human target cells remains a priority
in view of continuing concern about worldwide exposures
and the risks they pose (Hughes et al., 2007). To this end, the
roles of arsenic as a copromoter in mouse epidermis
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expressing a v-ras oncogene (Germolec et al., 1997) and as a
cocarcinogen with UV light (Burns et al., 2004) have been
demonstrated, and a mouse model for studying arsenic
carcinogenesis in other organs by transplacental exposure has
recently become available (Waalkes et al., 2004).
For investigative purposes, keratinocyte cultures provide a
good model for studying actions of toxic agents that adversely
affect the skin. Epidermal cells, propagated with 3T3 feeder
layer support, exhibit many characteristics of epidermis
in vivo, including stratification, expression of specific differ-
entiation markers, and production of enlarged superficial
squames (Green, 1979), and they readily adopt normal histo-
logy after grafting onto human subjects (Compton, 1996).
Treatment of cultured human epidermal cells with arsenite
suppresses differentiation marker expression (Kachinskas et al.,
1997) while maintaining proliferative potential, suggesting
that it interferes with important signal transduction pathways
(Jessen et al., 2001). Identifying these pathways, particularly if
they affect the fate of germinative cells, could help to elucidate
the influence of arsenic on the neoplastic process in vivo. The
plausibility of a connection to carcinogenesis is supported by
observations that arsenite maintains elevated b-catenin and
b1-integrin levels in the cultures as well as rapid adherence of
keratinocytes to type IV collagen upon passage (Patterson
et al., 2005), characteristics of populations enriched in
putative stem cells (Jones and Watt, 1993).
The above-mentioned effects of arsenite all require active
EGFR as they are prevented by co-treatment with EGFR
inhibitors (Patterson and Rice, 2007). In contrast to EGFR
signaling, insulin/insulin-like growth factor (IGF-I) signaling
in post-confluent keratinocyte cultures decreases proliferative
potential (Patterson and Rice, 2007) and increases differen-
tiation marker expression (unpublished), effects that are
largely prevented by arsenite exposure. The observation that
arsenite and Notch signaling have opposite effects in
keratinocytes on proliferative potential and differentiation
prompted the present investigation to determine whether
Notch signaling is affected by arsenite exposure.
RESULTS
Arsenite suppresses NICD in parallel to differentiation
When keratinocyte cultures reach confluence, their differ-
entiated state increases during the next 10 days while their
proliferative potential declines, phenomena that are largely
prevented by arsenite treatment (Patterson et al., 2005).
Immunoblotting of extracts from normal human epidermal
cells (Figure 1a) or from the spontaneously immortalized
keratinocyte (SIK) cell line (Figure 1b) with antiserum specific
for NICD, the activated form of Notch1, showed that this
g-secretase cleavage product increased after confluence in
parallel to the differentiation marker proteins keratin 10 (K10)
and involucrin. All of these changes were suppressed by
arsenite treatment (Figures 1a and b). Although arsenite,
antimonite, vanadate, chromate, and cadmium all suppress
differentiation marker expression (Rea et al., 2003), only
arsenite and antimonite are able to preserve colony-forming
ability (Patterson et al., 2005) and suppress NICD accumula-
tion (Figure 1c).
When keratinocytes are placed in suspension, they display
a rapid reduction in colony-forming ability as they become
terminally differentiated, a process that arsenite treatment
impedes (Patterson et al., 2005). In suspension culture, NICD
levels increased after 1 day, and arsenite prevented this effect
(Figure 2a). In addition, after 1 day in suspension, Hes1
mRNA, a transcriptional Notch1 target, was induced in the
absence but not in the presence of arsenite (Figure 2b).
c-Secretase inhibition mimics arsenite in altering keratinocyte
differentiation and proliferative potential
To investigate whether interruption of Notch signaling alone
would replicate the consequences of arsenite exposure, cells
were treated in parallel with arsenite or with the specific
g-secretase inhibitor, DAPT (N-(N-(3,5-difluorophenacetyl)-
L-alanyl)-S-phenylglycine t-butyl ester). DAPT potently sup-
pressed NICD accumulation with effects similar to those
achieved by arsenite treatment (Figure 3a). Furthermore,
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Figure 1. Suppression of NICD and differentiation in keratinocytes by
arsenite. Starting at 90% confluence, normal (a) epidermal or (b) SIK cultures
were treated with 2 mM arsenite for the indicated number of days. (c) SIK
cultures were treated with 2 mM arsenite, 3 mM vanadate, 5 mM chromate,
10mM cadmium, or 5 mM antimonite as indicated for 11 days. Immunoblot
analysis of NICD was performed using cleaved Notch1 (Val1744) antibody,
which detects endogenous levels of the cytosolic domain of Notch1
only when cleaved between Gly1743 and Val1744. b-Actin was used as
loading control. The dashed line in panel b separates two different blots.
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g-secretase inhibition by arsenite or DAPT treatment led
to suppression of Jagged1 protein and mRNA as well as
differentiation marker proteins and mRNAs (Figures 3a
and b), although the amount of suppression by arsenite and
DAPT was not identical, likely due to additional targets of
each agent.
N-(N-(3,5-difluorophenacetyl)-L-alanyl)-S-phenylglycine
t-butyl ester and arsenite treatment individually decreased
cell size (Figure 3c) and increased colony-forming efficiency
(CFE) compared with untreated cultures (Figure 3d). In
general, cotreatment with DAPT and arsenite had little
additive effect on differentiation marker or Jagged1 mRNA
expression (Figure 3b), cell size (Figure 3c), or CFE (Figure 3d).
Arsenite suppresses Notch1 processing at a step after ligand
binding
To find whether arsenite suppression of Jagged1 protein
reflected a transcriptional effect, mRNA levels were mea-
sured as a function of time after confluence. As shown in
Figure 4, expression approximately doubled after 2 weeks. By
contrast, treatment of the cultures with arsenite greatly
suppressed the mRNA levels so that after that time the levels
differed by an order of magnitude. This observation raised the
possibility that arsenite could produce its effects downstream of
NICD in this fashion.
When cultures were treated with a synthetic peptide derived
from Jagged1 that has Notch agonist activity in vitro and
stimulates terminal differentiation and cornification of human
keratinocytes (Nickoloff et al., 2002), NICD levels increased
(Figure 5a) and involucrin and K10 mRNAs were induced
(Figure 5b). Furthermore, CFE was reduced to half with Jagged1
treatment (Figure 5c). In the presence of the Jagged1 peptide,
however, arsenite treatment still suppressed NICD level and
differentiation marker expression while preserving proli-
ferative potential (Figure 5), indicating that arsenite also targets
Notch1 signaling regardless of ligand availability.
Regulation of Notch signaling by EGF and insulin/IGF-I
receptors
Treatment of cultures with the EGFR tyrosine kinase inhi-
bitor AG1478 alone enhanced NICD accumulation and, in
the presence of arsenite, it completely reversed arsenite
suppression of NICD, Jagged1, and K10 (Figure 6a). In these
experiments, the inhibitor suppressed EGF-mediated phos-
phorylation of tyrosines 1068 and 1173 without altering
EGFR protein levels (Figure 6b) in line with known effects of
EGFR inhibition (Peus et al., 1997).
In three independent experiments, 9-day treatment
with arsenite suppressed the expression not only of involucrin
and K10 mRNAs (to 2±1 and 2±2%, respectively), but also
of Jagged1 and Hes1 (to 42±12 and 55±6%, respectively,
of untreated control values). This action was also prevented
by treatment with AG1478 as shown by the representative
experiment in Table 1. In these experiments, inhibition of
EGFR activity by treatment with AG1478 alone stimulated
levels of each mRNA, and cotreatment with arsenite resulted
in levels close to those of untreated control cultures.
Standard keratinocyte culture medium contains a high
concentration of insulin to stimulate IGF-I signaling. In post-
confluent cells, removal of insulin increased proliferative
potential (Patterson and Rice, 2007) and decreased NICD,
Jagged1, involucrin, and K10 (Figure 6c). These effects were
independent of EGFR signaling, as they were unchanged in
the presence of the inhibitor AG1478.
DISCUSSION
Present results show clear inhibition by arsenite of Notch1
signaling components (NICD, Jagged1, Hes1) that likely
contribute to the expression of differentiation features (K1,
K10, involucrin, cell size) and germinative capability after
confluence. This finding contributes to our understanding of
the actions of arsenite inasmuch as Notch1 signaling is
known to affect the balance of germinative cell persistence
versus their loss through differentiation. By contrast, and
showing the specificity of arsenite, the actions of cadmium,
vandate, and chromate in suppressing differentiation (Rea
et al., 2003) appear not to be mediated through the Notch1
pathway, as neither proliferative potential (Patterson et al.,
2005) nor NICD level were altered. The fact that antimonite
has an effect similar to arsenite is consistent with our previous
finding that these agents preserve proliferative potential
similarly (Patterson and Rice, 2007).
Insulin, probably acting through the IGF-I receptor, has
been shown to be responsible for the loss of proliferative
potential and decline of EGFR levels after confluence. These
effects are largely prevented by arsenite and require the
activity of the EGFR (Patterson and Rice, 2007). Present
results extend our knowledge by showing that NICD levels
and differentiation markers are stimulated by insulin in the
medium and are overcome by the combined action of
arsenite and EGFR. These results lead to the following model.
In confluent keratinocytes, IGF-I receptor signaling generates
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Figure 2. Arsenite suppression of NICD protein and Hes1 mRNA in
suspension culture. (a) Immunoblots of NICD and b-actin (loading control)
performed on extracts of SIK before (0) and after 1 day (1) in suspension.
(b) Values for Hes1 mRNA expression (mean±SD), measured using real-time
PCR, are given relative to mRNA in untreated SIK cultures at zero days
and normalized to 18S RNA. The difference between treated and untreated
samples after 1-day suspension was significant (*Po0.05).
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a pro-differentiation signal, leading to loss of EGFR, followed
by loss of proliferative potential and accumulation of NICD
and differentiation markers. Arsenite, by preventing loss of
EGFR, suppresses this process. In the absence of insulin,
addition of an EGFR inhibitor has no effect on NICD or differen-
tiation markers, signifying that the role of EGFR signaling is to
oppose a pro-differentiation signal generated by insulin.
Notch1 acts as a tumor suppressor in mouse skin where its
ablation increases both spontaneous and chemical carcino-
gen-induced basal cell carcinomas (Nicolas et al., 2003).
In addition, suppression of Notch signaling by decreased
g-secretase activity due to decreased presenilin 1 (Xia et al.,
2001) or nicastrin (Li et al., 2007) or due to expression of a
dominant negative Notch inhibitor (Proweller et al., 2006)
also increases skin tumors, mostly squamous cell carcinomas.
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Figure 3. Inhibition of c-secretase activity preserves proliferative potential of keratinocytes and suppresses differentiation. SIK cultures were treated 1 day
before confluence with 2mM arsenite and/or with (a) the indicated concentrations of DAPT or (b–d) 10 mM DAPT. After 7 days of treatment, cultures were
harvested and assayed. (a) Immunoblot analysis was performed using antibodies to the indicated proteins; b-actin was used as a loading control. (b) mRNA levels
of K1 and K10, involucrin (Inv), and Jagged1 (Jag1) were measured using real-time PCR. mRNA expression, normalized to endogenous 18S RNA, is presented
relative to untreated cultures (value of 1). (c) Distribution of cell sizes from treated and untreated cultures. (d) Significant differences in CFE between untreated
and each treatment (*Po0.01). Each panel is representative of two independent experiments. Values in panels b and d are mean±SD.
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Figure 4. Time course of Jagged1 mRNA accumulation in SIK cultures with
and without 2 lM arsenite treatment. Values (mean±SD) are given relative
to untreated cultures harvested after 4 days and normalized to 18S RNA.
Significant differences between untreated and arsenite-treated samples
(*Po0.05, **Po0.01) are representative of five independent experiments.
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In all of these cases, nuclear b-catenin was increased
in neoplastic lesions, reminiscent of the increase observed
after chronic exposure of cultured keratinocytes to arsenite
(Patterson et al., 2005). In epidermis, Notch expression is
upregulated in suprabasal layers and, in cultured keratino-
cytes, activation results in increased differentiation (reviewed
by Watt et al., 2008). Present findings, consistent with
premature or enhanced differentiation upon EGFR inhibition
(Peus et al., 1997), suggest that increased EGFR signaling
in epidermis leads to decreased Notch signaling. Consistent
with this expectation, increased EGFR signaling is often
observed in human and mouse squamous cell carcinomas,
and its disruption results in decreased growth of v-rasHa
papillomas, interpreted as a requirement for EGFR in main-
taining the proliferative population (Hansen et al., 2000).
These observations suggest that arsenite increases skin cancer
because it increases or prolongs EGFR signaling, resulting in
maintenance of the proliferative population (carcinogen target
cells) and decreased Notch activation, thereby preventing loss
of initiated cells due to differentiation.
The molecular target of arsenite that reduces NICD
production remains to be identified. Arsenite prevented cell
responses to Jagged1, indicating that it is acting downstream
of ligand production. Exposure to arsenite could alter
interaction of Notch1 with activating ligands, release of
NICD by proteolysis or half-life of NICD. Notch1 mRNA,
quantified by real-time PCR analysis, and precursor protein
levels, detected with a C-terminal antibody (unpublished)
were not altered by arsenite. If NICD suppression was due to
direct inhibition of g-secretase activity, then proteolysis of
other g-secretase substrates, such as E-cadherin, should be
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Figure 5. Jagged1 peptide effects on arsenite-treated keratinocytes. SIK
cultures that were 90% confluent were pretreated for 24 hours with 2 mM
arsenite before addition of synthetic Jagged1 peptide into the medium to
obtain a final concentration of 40 mM. Cultures were treated for 3 days
and then harvested and assayed. (a) Protein levels of NICD were detected
by immunoblotting; b-actin was used as loading control. (b) mRNA levels
of involucrin and K10 were measured by real-time PCR. Values are given
relative to mRNA in untreated cultures, indicated by the horizontal dotted
line. (c) CFE after Jagged1 or arsenite treatment. The results (mean±SD)
are representative of two independent experiments, where * indicates the
values for cultures treated with Jagged1±arsenite that were significantly
different (Po0.02).
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Figure 6. EGFR inhibition induces Notch1 activation and reverses the
arsenite effect on Notch1. (a) SIK cultures (90% confluent) were pretreated
for 1 hour with 1 mM AG1478 followed by treatment with 2mM arsenite for 4
days. Cultures were harvested and subjected to immunoblot analysis using
antibodies as indicated; b-actin was used as a loading control. Results are
representative of three independent experiments. (b) Demonstration of
AG1478 efficacy in EGFR inhibition using antibodies to autophosphorylation
sites. Confluent SIK cultures were treated with AG1478 (or solvent control) for
1 hour before EGF addition and harvested at the indicated times. (c) SIK
cultures were grown to confluence in the presence of insulin, which was then
removed from those cultures indicated by (). Cultures were treated with
AG1478 as indicated (added at each medium change) starting at confluence
and harvested 2 weeks later.
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altered by arsenite treatment. Although DAPT altered the
processing of both E-cadherin and NICD, the processed forms
of E-cadherin in arsenite-treated cells were identical to those
in untreated cells (unpublished), suggesting that arsenite
reduces NICD by another mechanism.
On the other hand, as elements of membrane dynamics
influence Notch signaling, arsenite could interfere with
a processing step such as ubiquitination or endocytosis
(Gupta-Rossi et al., 2004; Le Borgne, 2006). Several negative
regulators of Notch signaling have been identified; Numb
and Sel10 promote ubiquitination and degradation of Notch
(McGill and McGlade, 2003; Welcker and Clurman, 2008),
whereas LRF is a transcriptional repressor that prevents
activation of Notch (Maeda et al., 2007). In preliminary
experiments, arsenite treatment had little effect (o2-fold) on
levels of mRNAs encoding these proteins, although protein
levels or function have not yet been examined. As arsenite
also alters EGF receptor levels in keratinocytes (Patterson
and Rice, 2007), the possibility of more global effects on
trafficking of membrane proteins merits further investigation.
Elucidating the details of Notch signaling is important to
understand development and differentiation in a variety of
cell types. In contrast to its tumor-suppressive action in the
skin, Notch signaling has attracted attention because activa-
ting mutations can promote growth of hematopoietic and
certain other neoplasias (Miele et al., 2006). Use of arsenic to
induce remission of acute promyelocytic leukemia appears to
be more effective than all-trans retinoic acid in removing
leukemic stem cells (Zheng et al., 2007). If arsenite inhibits
NICD generation in these cells as it does in keratinocytes, this
function could contribute to its effectiveness. Understanding
the mechanism of arsenite action could lead to other
potential clinical uses as well as alert clinicians to possible
side effects of its use as a therapeutic.
MATERIALS AND METHODS
Cell culture
Cultures of SIK (Rice et al., 1993) or normal human epidermal
keratinocytes were propagated in DMEM/F12 (2:1) medium supple-
mented with fetal bovine serum (5%), hydrocortisone (0.4mgml1), EGF
(10ngml1), adenine (0.18mM), insulin (5mgml1), transferrin
(5mgml1), and triiodothyronine (20pM) using a feeder layer of lethally
irradiated 3T3 cells (Allen-Hoffmann and Rheinwald, 1984). Medium
was further supplemented with cholera toxin (10ngml1) at inoculation,
then with EGF (10ngml1) starting at the first medium change. Cells
were grown until just before confluence with medium changes at 3- to
4-day intervals, at which time they were treated with 2mM sodium
arsenite, 5mM potassium antimony tartrate, 3mM sodium vanadate, 5mM
potassium chromate, 10mM cadmium chloride (all from Fisher Scientific,
Pittsburgh, PA) as indicated, or designated concentrations of DAPT from
EMD Bioscience (La Jolla, CA). In certain instances, cells were first
pretreated for 1hour with 1mM AG1478 (LC Laboratories, Woburn, MA).
Suspension-induced terminal differentiation
Keratinocyte cultures were treated a day before confluence with
2mM sodium arsenite for 24 hours. At confluence, any remaining 3T3
cells were removed with EDTA, and the keratinocytes were
dispersed by trypsinization. Two million cells were suspended in
10ml of culture medium containing 1.4% methylcellulose (Green,
1977) with continuing arsenite treatment in suspension for 1 day. At
the indicated time points, cells were diluted tenfold with phosphate-
buffered saline and recovered by low-speed centrifugation. After
three washes with phosphate-buffered saline, the cells were used for
immunoblotting or real-time RT-PCR as indicated.
Colony-forming efficiency assay
Cultures were treated for indicated times, trypsinized, and 1,000 or
10,000 cells were inoculated in 6 cm dishes. Cells were allowed to
grow with feeder layer support until most were 2–5mm in diameter,
typically for 1–2 weeks. The colonies were fixed and visualized by
staining with Rhodanile blue (Rheinwald and Green, 1975). CFE
values (%) are presented as the number of macroscopic colonies
(450 cells) divided by the number of cells inoculated times 100.
Cell size determination
Cultures were treated as indicated and trypsinized, and the size
distribution was analyzed with a Beckman Coulter Multisizer3.
Representative graphs were obtained using Multisizer 3.51 software.
Jagged1 peptide treatment
A synthetic peptide corresponding to Jagged1 residues 188–204
(CDDYYYGFGCNKFCRPR) (Nickoloff et al., 2002) was purchased
from GeneMed Synthesis (San Francisco, CA). Peptide stock
solutions (10mM) were prepared in sterile distilled water, aliquoted,
and stored frozen. Cultures were treated with 40 mM Jagged1 peptide
diluted in medium immediately before use.
Immunoblot analysis
Cells were scraped directly into buffer containing 2% SDS, 62.5mM
Tris (pH 6.8), and 10% glycerol. Protein was measured with
bicinchoninic acid (Pierce Chem Co, Rockford, IL) before addition of
dithiothreitol to 50mM. Equal amounts (20mg) of protein were
submitted to SDS-PAGE, transferred to polyvinyldifluoride membranes,
blocked with 5% dry milk in TBST, incubated with the indicated
antibodies, and detected using ECL Plus chemiluminescence detection
reagent (Amersham Biosciences, Piscataway, NJ). Antibodies were
obtained from the following sources: cleaved Notch1 (Val1744) and
Jagged1 rabbit monoclonal (Cell Signaling, Danvers MA), K10 mouse
monoclonal (NeoMarkers, Fremont, CA), b-actin mouse monoclonal
from Sigma (St Louis, MO), and involucrin (Rice and Green, 1979).
Table 1. Relative mRNA levels in SIK cultures treated
with arsenite and AG1478
% of untreated1
Marker Arsenite AG1478 Arsenite+AG1478
Hes1 57±4 158±3 107±2
Jagged1 38±0.4 171±2 119±4
Keratin 10 0.4±0.01 366±9 138±1
Involucrin 2.3±0.2 230±12 86±2
1mRNA values, measured by real-time PCR and expressed relative to
those of parallel untreated samples (all normalized to GUSB), are means
and standard deviations of duplicate samples. The experiment was
repeated four times with similar results.
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Real-time reverse transcription PCR
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA).
To avoid amplification of genomic DNA, RNA was pretreated with
DNase (DNA-free Ambion kit, Applied Bioststems, Foster City, CA).
c-DNA synthesis was performed using High-capacity cDNA archive kit
(Applied Biosystems). The cDNA served as a template in quantitative
real-time PCR utilizing TaqMan Fast Universal PCR Master Mix and
TaqMan Gene Expression inventoried assay probes, which amplified
sequences across intron/exon boundaries (Applied Biosystems). The
assays were performed on an ABI 7,500 Fast Sequence Detection
System. mRNA expression was normalized to 18S or GUSB RNA,
neither of which appeared to change with the treatments.
Statistics
Student’s two-tailed t-tests were conducted in Excel for estimation of
significance.
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